SIGNIFICANT REDUCTION IN THE DIAGNOSIS OF BARRETT'S ESOPHAGUS AND RELATED DYSPLASIA DURING THE COVID-19 PANDEMIC.
Sridevi K PokalaJ Lucas WilliamsJennifer L HolubAudrey H CalderwoodJason A DominitzPrasad G IyerNicholas J ShaheenSachin WaniPublished in: The American journal of gastroenterology (2023)
There was a significant decline in the number of BE and BE-related dysplasia diagnoses during the COVID-19 pandemic, with an almost 50% reduction in the amount of dysplasia diagnosed in the early pandemic. The absence of a compensatory increase in diagnoses in the pandemic-Phase II and III periods may result in deleterious downstream effects on esophageal adenocarcinoma morbidity and mortality.